- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/15 - Inhibiteurs de protéases, p. ex. antithrombine, antitrypsine, hirudine
Détention brevets de la classe C12N 15/15
Brevets de cette classe: 84
Historique des publications depuis 10 ans
|
8
|
3
|
6
|
1
|
4
|
4
|
2
|
3
|
0
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Wuhan Healthgen Biotechnology Corp | 29 |
3 |
| President and Fellows of Harvard College | 6030 |
2 |
| Mayo Foundation for Medical Education and Research | 3286 |
2 |
| Alteogen Inc. | 65 |
2 |
| Arrowhead Pharmaceuticals, Inc. | 318 |
2 |
| BioNTech AG | 74 |
2 |
| iNova Diagnostics, Inc. | 72 |
2 |
| Kunming Institute of Zoology, Chinese Academy of Sciences | 42 |
2 |
| leiden University Medical Center | 48 |
2 |
| Monash University | 721 |
2 |
| Suzhou Microdiag Biomedicine Co., Ltd | 3 |
2 |
| The University of North Carolina at Chapel Hill | 2063 |
2 |
| Janssen Pharmaceuticals, Inc. | 441 |
1 |
| Bayer Healthcare AG | 56 |
1 |
| Amgen Inc. | 4163 |
1 |
| Massachusetts Institute of Technology | 10130 |
1 |
| The General Hospital Corporation | 4797 |
1 |
| The Trustees of the University of Pennsylvania | 4376 |
1 |
| Novozymes A/S | 3335 |
1 |
| University of Florida Research Foundation, Inc. | 4079 |
1 |
| Autres propriétaires | 51 |